DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
41 hedge funds and large institutions have $3.81M invested in DMK Pharmaceuticals Corporation Common Stock in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
41
Holding in Top 10
–
Calls
$316K
Puts
$84K
Top Buyers
| 1 | +$223K | |
| 2 | +$53.5K | |
| 3 | +$28.2K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$27.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6K |
Top Sellers
| 1 | -$795K | |
| 2 | -$170K | |
| 3 | -$31K | |
| 4 |
JCM
Jacobi Capital Management
Pittston,
Pennsylvania
|
-$20K |
| 5 |
Squarepoint
New York
|
-$17K |